Literature DB >> 6835717

Human intestinal mucin in cystic fibrosis.

A Wesley, J Forstner, R Qureshi, M Mantle, G Forstner.   

Abstract

Human intestinal mucins from six subjects with Cystic Fibrosis (CF) and eight subjects without CF were prepared from tissue obtained at surgery (one case) and postmortem. Subjects were not age-matched, but the nonCF mucin was obtained from subjects with ages which bracketed those of the CF subjects. Cesium chloride analytical gradient ultracentrifugation showed that CF mucins were generally denser than nonCF mucins. Sedimentation coefficients were also higher in the CF samples. CF mucins were enriched in fucose, galactose, N-acetylglucosamine and total carbohydrate per mg protein and per oligosaccharide chain (mole/mole GalNAc). Fucose/sialic acid molar ratios were significantly higher in CF mucins, and the average oligosaccharide chain length was approximately three residues greater in CF as compared with nonCF mucins. There was no difference in amino acid profiles or the number of side chains per molecule. The mean sulfate content was higher in the CF mucins but not to a level of significance; however, in the eight mucins, sulfate content correlated positively with total carbohydrate, N-acetylglucosamine and galactose, and therefore increased with oligosaccharide chain length. CF intestinal mucin was therefore denser and more highly glycosylated than nonCF musin and probably contained more sulfate. The increase in glycosylation resulted from a rise in fucose, galactose, and N-acetylglucosamine without a concomitant rise in sialic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835717     DOI: 10.1203/00006450-198301000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Abnormal fucosylation of-ileal mucus in cystic fibrosis: II. A histochemical study using monoclonal antibodies to fucosyl oligosaccharides.

Authors:  A King; M McLeish; S Thiru
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

3.  Abnormal fucosylation of ileal mucus in cystic fibrosis: I. A histochemical study using peroxidase labelled lectins.

Authors:  S Thiru; G Devereux; A King
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

4.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 5.  Small-intestinal abnormalities in cystic fibrosis patients.

Authors:  E Eggermont; K De Boeck
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

6.  The disulphide-bond content and rheological properties of intestinal mucins from normal subjects and patients with cystic fibrosis.

Authors:  M Mantle; G Stewart; G Zayas; M King
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

7.  Antigenic and structural features of goblet-cell mucin of human small intestine.

Authors:  M Mantle; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

8.  Biochemical characterization of rat colonic mucins secreted in response to Entamoeba histolytica.

Authors:  S K Tse; K Chadee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Effects of Yersinia enterocolitica infection on rabbit intestinal and colonic goblet cells and mucin: morphometrics, histochemistry, and biochemistry.

Authors:  M Mantle; E Atkins; J Kelly; E Thakore; A Buret; D G Gall
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Electron microprobe analysis of human labial gland secretory granules in cystic fibrosis.

Authors:  K Izutsu; D Johnson; M Schubert; E Wang; B Ramsey; A Tamarin; E Truelove; W Ensign; M Young
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.